Home/Artelo Biosciences/Steven D. Reich
SD

Steven D. Reich

Chief Medical Officer

Artelo Biosciences

Therapeutic Areas

Artelo Biosciences Pipeline

DrugIndicationPhase
ART27.13Cancer Anorexia-Cachexia Syndrome (CACS)Phase 2
ART26.12Solid Tumors (e.g., Prostate Cancer)Preclinical
ART12.11UndisclosedPreclinical